Editorial & Opinion
Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
العنوان: | Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390. |
---|---|
المؤلفون: | Endo M; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA., Roth MY; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA., Tylee TS; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA., DeSantis A; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA., Hirsch IB; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA. |
المصدر: | Diabetes care [Diabetes Care] 2023 May 01; Vol. 46 (5), pp. e118. |
نوع المنشور: | Letter; Comment |
اللغة: | English |
بيانات الدورية: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Alexandria Va : American Diabetes Association Original Publication: New York, American Diabetes Assn. |
مواضيع طبية MeSH: | Thyroid Neoplasms*/epidemiology , Diabetes Mellitus*/drug therapy , Diabetes Mellitus*/epidemiology, Humans ; Glucagon-Like Peptide-1 Receptor/agonists ; Hypoglycemic Agents |
التعليقات: | Comment on: Diabetes Care. 2023 Feb 1;46(2):384-390. (PMID: 36356111) Comment in: Diabetes Care. 2023 May 1;46(5):e121-e122. (PMID: 37185689) |
المشرفين على المادة: | 0 (Glucagon-Like Peptide-1 Receptor) 0 (Hypoglycemic Agents) |
تواريخ الأحداث: | Date Created: 20230515 Date Completed: 20230517 Latest Revision: 20230521 |
رمز التحديث: | 20230521 |
DOI: | 10.2337/dc22-2454 |
PMID: | 37185687 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1935-5548 |
---|---|
DOI: | 10.2337/dc22-2454 |